Canada Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers
Rubicon Organics Inc (ROMJF) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Market Challenges
Rubicon Organics Inc (ROMJF) reports record net revenue and successful product launches, while navigating market pressures and competition. Nov 15, 2024
GuruFocus News Drug Manufacturers
Cronos Group Inc (CRON) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion Amid Market Challenges
Cronos Group Inc (CRON) reports significant revenue growth and improved cash flow, while navigating competitive pressures and regulatory uncertainties. Nov 13, 2024
GuruFocus News Drug Manufacturers
Canopy Growth Corp (CGC) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic Growth Opportunities
Despite a dip in consolidated net revenue, Canopy Growth Corp (CGC) shows resilience with significant growth in international markets and strategic cost reductions. Nov 09, 2024
GuruFocus News Drug Manufacturers
Medexus Pharmaceuticals Inc (MEDXF) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and Preparing for Treosulfan Launch
Despite a dip in revenue, Medexus Pharmaceuticals Inc (MEDXF) shows resilience with improved EBITDA and strategic preparations for future growth. Nov 09, 2024
GuruFocus News Drug Manufacturers
HLS Therapeutics Inc (HLTRF) Q3 2024 Earnings Call Highlights: Strategic Debt Reduction and Vascepa Growth Drive Positive Outlook
Despite revenue challenges, HLS Therapeutics Inc (HLTRF) focuses on debt reduction and Vascepa expansion to strengthen its financial position. Nov 08, 2024